Schroder Investment Management Group
SUPN icon

Schroder Investment Management Group’s Supernus Pharmaceuticals SUPN Stock Holding History

Schroder Investment Management Group’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$17.2M Buy
368,017
+191,941
+109% +$9.22M 0.01% 572
2026
Q1 		$8.69M Sell
176,076
-13,866
-7% -$706K 0.01% 693
2025
Q4 		$9.48M Buy
+189,942
New +$9.24M 0.01% 647
2025
Q3 		– Sell
-266,927
Closed -$8.41M – 1261
2025
Q2 		$8.41M Sell
266,927
-2,553
-0.9% -$81.8K 0.01% 666
2025
Q1 		$8.7M Sell
269,480
-29,177
-10% -$1.03M 0.01% 663
2024
Q4 		$11M Sell
298,657
-216,640
-42% -$7.63M 0.01% 642
2024
Q3 		$15.8M Buy
515,297
+7,200
+1% +$225K 0.02% 578
2024
Q2 		$13.6M Buy
508,097
+150,416
+42% +$4.36M 0.02% 572
2024
Q1 		$12.2M Sell
357,681
-184,292
-34% -$5.49M 0.01% 609
2023
Q4 		$15.7M Buy
+541,973
New +$14.4M 0.02% 538
2020
Q3 		– Sell
-1,360
Closed -$32K – 1388
2020
Q2 		$32K Sell
1,360
-10,900
-89% -$241K ﹤0.01% 1200
2020
Q1 		$224K Sell
12,260
-881
-7% -$18.5K ﹤0.01% 1088
2019
Q4 		$312K Buy
+13,141
New +$319K ﹤0.01% 1112
2018
Q3 		– Sell
-15,343
Closed -$895K – 1335
2018
Q2 		$895K Buy
15,343
+76
+0.5% +$3.94K ﹤0.01% 950
2018
Q1 		$699K Buy
15,267
+1,643
+12% +$68.6K ﹤0.01% 1011
2017
Q4 		$543K Buy
13,624
+5,160
+61% +$204K ﹤0.01% 1086
2017
Q3 		$333K Buy
+8,464
New +$366K ﹤0.01% 1135

Other funds holding SUPN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return

Schroder Investment Management Group's SUPN Position: Q2 2026 in Review

Schroder Investment Management Group increased its Supernus Pharmaceuticals (SUPN) stake by 109% in Q2 2026, buying an estimated $9.22M and bringing the position to 368,017 shares worth $17.2M. The position accounts for 0.01% of the portfolio, ranked #572.

Schroder Investment Management Group first reported a position in SUPN in Q3 2017 and has held it in 17 quarters since. 335 funds tracked by Wall St. Rank hold SUPN as of Q2 2026.

  • Schroder Investment Management Group held 368,017 shares of Supernus Pharmaceuticals worth $17.2M as of Q2 2026.
  • Schroder Investment Management Group bought 191,941 Supernus Pharmaceuticals shares in Q2 2026, an estimated $9.22M.
  • Supernus Pharmaceuticals made up 0.01% of Schroder Investment Management Group's portfolio in Q2 2026, its #572 holding.
  • Schroder Investment Management Group first reported a position in Supernus Pharmaceuticals in Q3 2017 and has held it in 17 quarters since.
  • 335 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q2 2026.

Based on Schroder Investment Management Group's 13F filing for Q2 2026, filed 13 Aug 2026.